stry or Bioorganic and Medicinal Chemistry. Previous recipients include: Albert Eschenmoser, Elias J. Corey, Gilbert Stork, Arthur J. Birch, Michael J.S. Dewar, William S. Johnson, Ryoji Noyori; K. Barry Sharpless, Alan R. Battersby; A. Ian Scott, Samuel Danishefsky, Stuart L. Schreiber, David A. Evans, Teruaki Mukaiyama, Henri B. Kagan, Peter B. Dervan, Yoshito Kishi, Kyriacos C. Nicolaou, Robert H. Grubbs, Dieter Seebach, Koji Nakanishi, Bernd Giese, Hisashi Yamamoto, J. Fraser Stoddart, Larry E. Overman, Steven V. Ley and Satoshi Ōmura.
The Tetrahedron Prize will be presented to Professor Reetz at the Fall 2012 American Chemical Society National Meeting in Philadelphia, USA.
For more information on the Tetrahedron Prize please click here.
About Tetrahedron Publications
Elsevier's Tetrahedron cluster of journals consists of: Tetrahedron, Tetrahedron Letters, Tetrahedron Assymetry, Bioorganic and Medicinal Chemistry and Bioorganic and Medicinal Chemistry Letters. All these journals provide an international forum for the publication of research in all areas of (bio)organic and medicinal chemistry.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include Page: 1 2 3 Related biology technology :1
. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System2
. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program3
. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists4
. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions5
. BioSpace Spotlights Leading Life Science Community6
. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai7
. CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding8
. Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis9
. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India10
. Californias Industrial Biotechnology Workforce: Creating Jobs and Leading Innovation11
. OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals